Good News for Breast Cancer Patients (with HER2-positive)

The first paragraph summed it well - drastic price reduction would enable more breast cancer patients with HER2-positive to be treated with trastuzumab. Trastuzumab treatment is heavily subsidised for patients who fits certain strict criterias in government hospitals. For these patients, this news won't affect them. Who will it benefit then? Besides adhering to KKM …

Another Good News for Breast Cancer Patients (with ER positive, HER2 negative)

In advanced breast cancer, two criteria when deciding suitability for hormonal therapy are: Estrogen receptor (ER) positive and HER2 negative NOT in visceral crisis Visceral crisis is defined as severe organ dysfunction as assessed by signs and symptoms, laboratory studies and rapid progression of disease. Visceral crisis is not the mere presence of visceral metastases …